Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000233859 | SCV000290264 | likely benign | Adams-Oliver syndrome 5 | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001589195 | SCV001826179 | uncertain significance | not provided | 2023-12-21 | criteria provided, single submitter | clinical testing | Reported in an Australian female with an atrial septal defect (ASD), whose mother and maternal grandmother also had an ASD (PMID: 25500235); however, while the p.(G1091S) variant was found in her affected mother, it was not detected in her affected maternal grandmother; Also reported in two Dutch individuals, one individual with a bicuspid aortic valve and one individual with hypoplastic left heart syndrome, and both individuals inherited the variant from their mothers who had normal echocardiograms (PMID: 26820064); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25803323, 24030381, 29217782, 26820064, 25500235) |
Genome- |
RCV000233859 | SCV002553503 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270042 | SCV002553505 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444917 | SCV002612547 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-09-26 | criteria provided, single submitter | clinical testing | The c.3271G>A (p.G1091S) alteration is located in exon 20 (coding exon 20) of the NOTCH1 gene. This alteration results from a G to A substitution at nucleotide position 3271, causing the glycine (G) at amino acid position 1091 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Clinical Genetics Laboratory, |
RCV001589195 | SCV005197002 | uncertain significance | not provided | 2023-03-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001589195 | SCV001928815 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001589195 | SCV001956845 | uncertain significance | not provided | no assertion criteria provided | clinical testing |